KDR and neoplasm: Against a target of VEGFR-2 tyrosine kinase VEGFR-2 plays a main receptor function in tumor angiogenesis mediated by VEGF, which prevents the activation of VEGFR-2 enzyme and limits VEGF signal transduction so as to inhibit tumor growth for cancer treatment.